Acquiring Company
Private Equity Consortium
Acquired Company
Syneos Health
Description
Syneos Health has been acquired by a consortium of private equity investors in a multibillion-dollar cash deal, resulting in the company's transition to a private entity. The acquisition, valued at several billion USD, marks the end of Syneos Health's time as a publicly traded company. With this move, the company aims to focus on enhancing operational efficiencies and growth outside public markets.
Don't miss Private Equity Consortium's next move
Get an email the moment Private Equity Consortium makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
M&A Insights
Based on deal dataFrequently asked
Who acquired Syneos Health?
Syneos Health was acquired by Private Equity Consortium. The deal was reported on September 5, 2026. A group of investors leading the bid to take EA private. The consortium includes Silver Lake, Saudi Arabia’s Public Investment Fund, and Jared Kushner’s Affinity Partners. Private Equity Consortium is privately held and operates in Angel Investment.
When did Private Equity Consortium acquire Syneos Health?
Private Equity Consortium's acquisition of Syneos Health was reported on September 5, 2026. Syneos Health has been acquired by a consortium of private equity investors in a multibillion-dollar cash deal, resulting in the company's transition to a private entity. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Syneos Health do?
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. It is privately held, operating in Biotechnology, and is based in Morrisville.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.